CS

Collin Spencer

Ph.D. Candidate, Biomedical AI @ Mount Sinai

New York, New York

Overview 

Collin Spencer is a Ph.D. Candidate in Biomedical AI at Mount Sinai in New York, with a background that includes co-founding a biotechnology startup, serving as a TechBio Venture Capital Fellow, and working on various research projects in computational biology and biotechnology. Spencer's career highlights include founding and directing partnerships at a biotechnology startup, and serving as a fellow in a tech venture capital firm, showcasing a strong entrepreneurial spirit and expertise in the biotech industry.

Work Experience 

  • Doctoral Candidate

    2020 - Current

    THESIS: Panos Roussos Lab, Fabian Theis Lab Thesis research investigates cellular state and gene regulatory network dynamics in Alzheimer's Disease and aging for therapeutic target discovery. ROTATION: Towfique Raj Lab Developed pipeline for aligning and quantifying microglia short-read RNA-seq to long-read PacBio Isoseq data ROTATION: Panos Roussos Lab Developed Watermelon, a deep learning method for imputing missing ChIP-seq assay data in Roadmap Epigenomics and learning functional genomic relations in health and disease

  • Co-Founder & Board Member

    2022

    OUTbio Greater New York is a 501(c)(3) nonprofit organization that seeks to empower and advance the LGBTQ+ community and its allies in the life sciences, biotechnology and affiliated industries, and to promote LGBTQ+ health and wellness.

  • TechBio Venture Capital Fellow

    2023 - 2024

    Sourced and advised pre-seed to Series A platform investment opportunities at the intersection of life sciences, computation, and engineering.

ARTIS Ventures is a venture capital firm that invests in category defining companies in TechBio, the intersection of technology and biology.

  • Schmidt Futures Research Fellow: Biotechnology Startup Operations

    2022 - 2024

    Developed a comprehensive playbook aimed at helping academic founders transition from lab-based research to launching successful biotech startups. Conducted extensive interviews with biotech founders, operators, and venture capitalists to synthesize actionable insights on key operational strategies, including business models, team-building, and scaling operations.

  • Co-Founder & Director of Partnerships, Nucleate NYC

    2021 - 2024

    Building the biotech ecosystem in NYC through collaborative partnerships and event planning with leading VCs, incubators, investors, law firms, and founders.

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

  • DAAD Scholar | Computational Biology

    2023 - 2024

    Research Fellow in the Fabian Theis lab, Institute for Computational Biology at Helmholtz Munich / TUM. Investigated cellular states and gene regulatory architecture of Alzheimer's disease progression with multiple instance learning and graph optimal transport.

  • Visiting Research Fellow | Fabian Theis Lab

    2023 - 2023

    Developing computational methods for single-cell trajectory inference of Alzheimer’s Disease progression, modeling the underlying molecular dynamics contributing to the emergence of clinical pathologies

  • Frequency Bio Fellow | Cohort 7

    2023 - 2023

Pillar VC invests in seed-stage companies, supporting unstoppable founders with capital, connections, coaching, and peer support.

  • Founder and Chair, Mental Health Joint Allocations Committee

    2018 - 2020

    After the shooting and death of a student experiencing first-episode psychosis, I fundraised, developed the grant structure, and oversaw the allocation of a $1,000,000 fund for mental health research, infrastructure, and services.

  • Undergraduate Researcher

    2018 - 2020

    Greg Gibson Lab -Developed novel machine learning clustering technique for utilizing dropouts in single-cell transcriptomics as a signal for tissue heterogeneity in Autism Spectrum Disorder -Investigated statistical mental health disparities among vulnerable populations at Georgia Tech and established $300,000 in funding to support programming and resources for vulnerable populations (e.g. LGBTQ+ and BIPOC)

  • Founder & Consortia Chair

    2018 - 2020

    Intercollegiate Mental Health Conference (http://mentalhealthconference.gatech.edu/) -Organized the Intercollegiate Mental Health Conference, the first national student-run mental health conference in the United States -Developed a taxonomy and comparative analysis of college mental health systems -Published a proceedings manual on the historical development, enactment, and efficacy of over 90 policies in college mental health -Translated research into $700,000 in grant funding for mental health infrastructure, resources, and research

  • Health Policy Specialist

    2019 - 2019

    Developed and legislated Georgia behavioral health Medicaid policy, enabling wraparound mental health services for children and young adults with severe autism.

  • Software Engineer

    2017 - 2017

    Aerosol Sciences Division of Aberdeen Proving Grounds Jana Kesavan Lab Conducted research for chemical and biological warfare defense.

Oxford Construction of Pennsylvania is specializing in building construction

Articles About Collin

Relevant Websites